Rockefeller University: This epigenetic switch could be targeted by new cancer therapies
March 11, 2026
March 11, 2026
NEW YORK, March 11 -- Rockefeller University posted the following news:
* * *
This epigenetic switch could be targeted by new cancer therapies
*
Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2, which regulates cell differentiation, identity, and plasticity, becomes dysfunctional. PRC2 has well-established links to breast, prostate, blood, and skin cancers, among other . . .
* * *
This epigenetic switch could be targeted by new cancer therapies
*
Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2, which regulates cell differentiation, identity, and plasticity, becomes dysfunctional. PRC2 has well-established links to breast, prostate, blood, and skin cancers, among other . . .